Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: An observational study

The Lancet Oncology

Volumn 13, Issue 3, 2012, Pages 256-264

  Amant, Frédéric ^a   Van Calsteren, Kristel ^a   Halaska, Michael J ^c   Gziri, Mina Mhallem ^a   Hui, Wei ^a   Lagae, Lieven ^a   Willemsen, Michèl A ^d   Kapusta, Livia ^e,f   Van Calster, Ben ^a   Wouters, Heidi ^a   Heyns, Liesbeth ^a   Han, Sileny N ^a   Tomek, Viktor ^g   Mertens, Luc ^b,h   Ottevanger, Petronella B ^e  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c CHARLES UNIVERSITY   (Czech Republic)

^d RADBOUD UNIVERSITY   (Netherlands)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f Edit Wolfson Medical Centre   (Israel)

^g UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^h HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; DAUNORUBICIN; DOXORUBICIN; EPIRUBICIN; IDARUBICIN;

ADOLESCENT; ADULT; AGE; ARTICLE; AUDIOMETRY; AUDITORY VERBAL LEARNING TEST; BIRTH; CANCER STAGING; CHILD; CHILD BEHAVIOR CHECKLIST; CHILD DEVELOPMENT; CHILDREN'S MEMORY SCALE; CLINICAL ASSESSMENT; COGNITIVE DEFECT; COGNITIVE DEVELOPMENT; COHORT ANALYSIS; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; GENDER; GESTATIONAL AGE; HEART DISEASE; HUMAN; INTELLIGENCE QUOTIENT; MAJOR CLINICAL STUDY; MALE; MATERNAL CANCER; MATERNAL DISEASE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEUROLOGIC EXAMINATION; NEWBORN; OBSERVATIONAL STUDY; PREMATURITY; PRENATAL DRUG EXPOSURE; PRESCHOOL CHILD; PRIORITY JOURNAL; QUESTIONNAIRE; SCHOOL CHILD; TEST OF EVERYDAY ATTENTION FOR CHILDREN; TREATMENT OUTCOME;

ADOLESCENT; ADOLESCENT DEVELOPMENT; AGE FACTORS; ANTINEOPLASTIC AGENTS; ATTENTION; CHECKLIST; CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; COGNITION; COGNITION DISORDERS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EUROPE; FEMALE; GESTATIONAL AGE; HEART DISEASES; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INTELLIGENCE TESTS; LINEAR MODELS; MALE; MEMORY; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PREMATURE BIRTH; PRENATAL EXPOSURE DELAYED EFFECTS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS;

EID: 84857502250     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(11)70363-1     Document Type: Article

References (37)

1. Creskoff A, Fitz-Hugh TJ, Frost J Urethane therapy in leukemia. Blood 1948, 3:896-910.
2. Amant F, Van Calsteren K, Halaska MJ, et al. Gynecologic cancers in pregnancy: guidelines of an international consensus meeting. Int J Gynecol Cancer 2009, 19(suppl 1):S1-12.
3. Amant F, Loibl S, Neven P, Van Calsteren K Breast cancer in pregnancy. Lancet 2012, 379:570-579.
4. Nieminen U, Remes N Malignancy during pregnancy. Acta Obstet Gynecol Scand 1970, 49:315-319.
5. Potter JF, Schoeneman M Metastasis of maternal cancer to the placenta and fetus. Cancer 1970, 25:380-388.
6. Stensheim H, Moller B, van Dijk T, Fossa SD Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study. J Clin Oncol 2009, 27:45-51.
7. Mennes M, Stiers P, Vandenbussche E, et al. Attention and information processing in survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only. Pediatr Blood Cancer 2005, 44:478-486.
8. Lohaugen GC, Gramstad A, Evensen KA, et al. Cognitive profile in young adults born preterm at very low birthweight. Dev Med Child Neurol 2010, 52:1133-1138.
9. van Baar AL, Vermaas J, Knots E, de Kleine MJ, Soons P Functioning at school age of moderately preterm children born at 32 to 36 weeks' gestational age. Pediatrics 2009, 124:251-257.
10. Van den Bergh BR, Van Calster B, Smits T, Van Huffel S, Lagae L Antenatal maternal anxiety is related to HPA-axis dysregulation and self-reported depressive symptoms in adolescence: a prospective study on the fetal origins of depressed mood. Neuropsychopharmacology 2008, 33:536-545.
11. Van Calsteren K, Heyns L, De Smet F, et al. Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes. J Clin Oncol 2010, 28:683-689.
12. Aviles A, Neri N Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma 2001, 2:173-177.
13. Hahn KM, Johnson PH, Gordon N, et al. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer 2006, 107:1219-1226.
14. Aviles A, Neri N, Nambo MJ Long-term evaluation of cardiac function in children who received anthracyclines during pregnancy. Ann Oncol 2006, 17:286-288.
15. van der Meulen BF, Ruiter SAJ, Spelberg HCL, Smrkovský M BSID-II-NL: Bayley Scales of Infant Development, 2nd edn-Nederlandse versie 2002, Swets Test Publishers, Lisse.
16. Manly T, Robertson I, Anderson V, Nimmo-Smit I TEA-Ch: test of everyday attention for children-Nederlandstalige vertaling 2007, Harcourt Test Publishers, Amsterdam.
17. Cohen MJ Children's memory scale 1997, Les Editions du Centre de Psychologie Appliquée, Paris.
18. Forrester G, Geffen G Performance measures of 7- to 15-year-old children on the auditory verbal learning test. Clin Neuropsychol 1991, 5:345-359.
19. Rey A L'examen clinique en psychologie 1964, Presses Universitaires de France, Paris.
20. Achenbach T Child behavior checklist/4-18, Nederlandstalige vertaling 1991, ASEBA, Erasmus MC-Sophia Kinderziekenhuis, Afdeling Kinder-en jeugdpsychiatrie, Rotterdam.
21. Roelants M, Hauspie R Groeicurven vlaanderen 2004 2004, Laboratorium voor Antropogenetica, Vrije Universiteit Brussel, Brussel.
22. Dickinson DF The normal ECG in childhood and adolescence. Heart 2005, 91:1626-1630.
23. Koenker R Quantile regression 2005, Cambridge University Press, New York.
24. Verrotti A, Spalice A, Ursitti F, et al. New trends in neuronal migration disorders. Eur J Paediatr Neurol 2010, 14:1-12.
25. Kaufman AS, Lichtenberger EO Essentials of WISC-III and WPPSI-R assessment 2000, John Wiley and Sons, New York, NY.
26. Isen J A meta-analytic assessment of Wechsler's P>V sign in antisocial populations. Clin Psychol Rev 2010, 30:423-435.
27. Cardonick E, Iacobucci A Use of chemotherapy during human pregnancy. Lancet Oncol 2004, 5:283-291.
28. Cardonick E, Usmani A, Ghaffar S Perinatal outcomes of a pregnancy complicated by cancer, including neonatal follow-up after in utero exposure to chemotherapy: results of an international registry. Am J Clin Oncol 2010, 33:221-228.
29. Daneman R, Zhou L, Kebede AA, Barres BA Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature 2010, 468:562-566.
30. Saunders NR, Knott GW, Dziegielewska KM Barriers in the immature brain. Cell Mol Neurobiol 2000, 20:29-40.
31. Virgintino D, Errede M, Girolamo F, et al. Fetal blood-brain barrier P-glycoprotein contributes to brain protection during human development. J Neuropathol Exp Neurol 2008, 67:50-61.
32. Schinkel AH, Wagenaar E, Mol CA, van Deemter L P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J Clin Invest 1996, 97:2517-2524.
33. Van Calsteren K, Verbesselt R, Devlieger R, et al. Transplacental transfer of paclitaxel, docetaxel, carboplatin, and trastuzumab in a baboon model. Int J Gynecol Cancer 2010, 20:1456-1464.
34. Van Calsteren K, Verbesselt R, Beijnen J, et al. Transplacental transfer of anthracyclines, vinblastine, and 4-hydroxy-cyclophosphamide in a baboon model. Gynecol Oncol 2010, 119:594-600.
35. Le Deley MC, Vassal G, Taibi A, Shamsaldin A, Leblanc T, Hartmann O High cumulative rate of secondary leukemia after continuous etoposide treatment for solid tumors in children and young adults. Pediatr Blood Cancer 2005, 45:25-31.
36. Reynoso EE, Shepherd FA, Messner HA, Farquharson HA, Garvey MB, Baker MA Acute leukemia during pregnancy: the Toronto Leukemia Study Group experience with long-term follow-up of children exposed in utero to chemotherapeutic agents. J Clin Oncol 1987, 5:1098-1106.
37. Mir O, Berveiller P, Ropert S, et al. Emerging therapeutic options for breast cancer chemotherapy during pregnancy. Ann Oncol 2008, 19:607-613.